VVOS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 birž. 2024 @ 21:48):
Our systems believe the stock currently is undervalued by 0.25% compare to its pairs and should correct upwards.

Stats
Šios dienos apimtis	21 149
Vidutinė apimtis	165 909
Rinkos kapitalizacija	7.40M
EPS	$-1.630 ( Q1 \| 2024-05-14 )
Kita pelno data	( $-0.920 ) 2024-08-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.200 (Sector) 42.63 (Industry) 0
ATR14	$0.0200 (0.92%)

AEMD -9.40%

AFIB 0.50%

AHCO 1.14%

AHPI 0.00%

ALGN 3.24%

ANIK -0.47%

APEN 0.00%

APYX 0.00%

ARAY 5.76%

ATEC 1.18%

AXDX 2.56%

AXGN 3.02%

AXNX -0.76%

AZYO 2.05%

BBLG 0.00%

BIOL 10.45%

BJDX -37.18%

BMRA 5.91%

BRKR 0.18%

BSGM 9.53%

BWAY -1.44%

CERS 0.00%

CFMS 0.44%

CLPT -2.15%

CODX 0.28%

CSII 0.15%

CTKB -1.48%

CTSO 1.97%

CUTR 0.72%

CVRX 6.23%

DCTH -3.25%

DXCM 2.89%

DYNT 0.41%

EAR -4.10%

ECOR 1.13%

EDAP -1.52%

ESTA -1.17%

FONR 2.56%

HJLI -1.98%

HSDT -1.92%

HSKA 0.00%

HYPR 7.64%

IART -0.82%

ICAD 0.01%

ICCM -2.07%

IINN 0.01%

INGN -0.58%

INMD -2.89%

IRIX 0.94%

IRMD -0.05%

IRTC 1.33%

ISO 0.00%

ITMR 0.00%

KIDS -0.38%

LHDX 0.00%

LIVN 0.51%

LNSR 1.69%

LUCD 3.89%

LUNG 1.65%

MASS -2.14%

MDGS 10.28%

MOTS 22.00%

MOVE 5.55%

MSON 0.00%

NAOV 0.41%

NARI 1.18%

NMRD 0.00%

NNOX -0.15%

NPCE 4.01%

NTUS 0.00%

NURO -1.07%

NUVA -2.24%

NUWE -35.45%

NVCN 0.00%

NVNO -3.85%

OBLN -5.86%

OFIX 0.85%

OM -6.55%

PACB -2.14%

PAVM 2.55%

PETV -16.20%

PODD 0.58%

PRCT -0.87%

PROF 2.51%

QIPT 2.95%

QTRX -1.50%

RCEL -0.50%

RPID -1.44%

RSLS -3.69%

RWLK 6.07%

RXST 0.73%

SGHT 2.71%

SIBN 3.25%

SIEN -18.69%

SILK -0.24%

SINT 2.09%

SOLY 0.00%

SRDX -0.02%

SRGA 0.00%

SRTS 1.64%

SWAV 0.00%

TBIO 2.71%

TCMD -0.44%

TELA 0.58%

THMO 4.17%

TIVC 0.77%

TLIS -4.72%

TMCI 4.91%

TMDI 0.00%

TMDX -0.54%

TNDM 0.66%

TNON 0.98%

UFPT -1.27%

VERO -2.59%

VIVE 0.00%

VMD 0.63%

VRAY 0.00%

VREX 0.28%

VVOS 2.30%

XAIR -1.37%

XENT 0.00%

ZIMV 1.52%

Insider Trading

Date	Person	Action	Amount	type
2023-06-20	Huntsman Ronald Kirk	Buy	14 000	Common Stock
2023-06-16	Huntsman Ronald Kirk	Buy	5 000	Common Stock
2023-06-16	Huntsman Ronald Kirk	Buy	10 000	Common Stock
2023-06-15	Huntsman Ronald Kirk	Buy	21	Common Stock
2023-06-14	Huntsman Ronald Kirk	Buy	10 000	Common Stock

INSIDER POWER
100.00
Last 44 transactions
Buy: 1 747 856 \| Sell: 433 336

Koreliacija (AI algo v.1.1b): Undervalued: 0.25% $2.18 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: -0.10 (neutral)

Trumpas: -0.43 (neutral)

Signal:(46.899) Neutral

Vivos Therapeutics, Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
AEHR	0.957
FFIE	0.948
WW	0.944
AVXL	0.939
VUZI	0.938
LGVN	0.937
EVOK	0.935
NWFL	0.935
INVZ	0.934
ASLE	0.929

10 Labiausiai neigiamai susiję koreliacijos
BSCO	-0.932
INBKZ	-0.927
DXJS	-0.914
APXI	-0.911
OXSQ	-0.908
ESTA	-0.908
NESR	-0.905
KRUS	-0.905
ADTH	-0.902
ACGL	-0.895

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Vivos Therapeutics, Inc. Koreliacija - Valiuta/Žaliavos

-0.03
( neutral )

-0.12
( neutral )

0.00
( neutral )

0.07
( neutral )

0.00
( neutral )

0.36
( neutral )

Vivos Therapeutics, Inc. Finansinės ataskaitos

Annual	2023
Pajamos:	$13.80M
Bruto pelnas:	$7.65M (55.43 %)
EPS:	$-11.14

FY	2023
Pajamos:	$13.80M
Bruto pelnas:	$7.65M (55.43 %)
EPS:	$-11.14

FY	2022
Pajamos:	$16.02M
Bruto pelnas:	$10.02M (62.52 %)
EPS:	$-24.62

FY	2021
Pajamos:	$16.89M
Bruto pelnas:	$11.87M (70.31 %)
EPS:	$-1.576

Financial Reports:

No articles found.

Vivos Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.